Montagu acquires RTI OEM business for $490m

Montagu will take a majority share of the business and is backing its existing management team. The firm drew equity from Montagu V, which closed on €2.75bn in 2015.

Headquartered in Florida, the business has four manufacturing sites in the US and in Germany. The company will remain debt-free immediately following the transaction, according to a statement. 

RTI's OEM business designs, develops, manufactures and distributes biological, metal and synthetic implants for a variety of surgical procedures including relating to the spine, sports medicine, general surgery and trauma. It employs more than 700 people.

This is Montagu's second carve-out in four months, following the acquisition of Jane's from IHS Markit.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• UK / Ireland
• Healthcare
• US
• Germany
• Montagu Private Equity
• Weil Gotshal & Manges